Allergan, Inc. (
) will begin trading ex-dividend on February 26, 2013. A cash
dividend payment of $0.05 per share is scheduled to be paid on
March 21, 2013. Shareholders who purchased AGN stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
marks the 22nd quarter that AGN has paid the same dividend.
The previous trading day's last sale of AGN was $105.87,
representing a -3.15% decrease from the 52 week high of $109.31 and
a 30.25% increase over the 52 week low of $81.28.
AGN is a part of the Consumer Durables sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). AGN's current earnings per share, an indicator of a company's
profitability, is $3.58. Zacks Investment Research reports AGN's
forecasted earnings growth in 2013 as 15.18%, compared to an
industry average of -.1%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to AGN through an Exchange
Traded Fund [ETF]?
The following ETF(s) have AGN as a top-10 holding:
- iShares Dow Jones U.S. Pharmaceutical Index Fund (
- Merrill Lynch Pharmaceutical HOLDRS (
- SPDR S&P Pharmaceuticals ETF (
- iShares MSCI Netherlands Index Fund (
- QuantShares U.S. Market Neutral Anti Beta Fund ETF (
The top-performing ETF of this group is EWN with an increase of
6.98% over the last 100 days. IHE has the highest percent weighting
of AGN at 4.89%.